Gadolinium phobia remains a very real danger in Europe, but practical measures can help to reduce the risk, according to Dr. Johannes Heverhagen, professor and head of radiology at the University Hospital of Bern in Switzerland. In advance of Friday’s ECR special focus session on the safety of gadolinium contrast agents for MRI, he also provides an update on the European Medicines Agency’s investigation, the results of which are expected soon.
Gadolinium phobia remains a very real danger in Europe, but practical measures can help to reduce the risk, according to Dr. Johannes Heverhagen, professor and head of radiology at the University Hospital of Bern in Switzerland. In advance of Friday’s ECR special focus session on the safety of gadolinium contrast agents for MRI, he also provides an update on the European Medicines Agency’s investigation, the results of which are expected soon.Video from ECR 2017: Dr. Johannes Heverhagen on gadolinium contrast
Mar 1, 2017
Latest in Home
PET links brain receptor to emotional numbing in PTSD
August 25, 2025
CEM, DBT show promise for preoperative breast cancer staging
August 25, 2025
3D DEXA reveals lower bone density in diabetes patients
August 22, 2025